The Effects Of Coenzyme Q10 Supplementation On Cardiometabolic Markers In Overweight Type 2 Diabetic Patients With Stable Myocardial Infarction: A Randomized, Double-blind, Placebo-controlled Trial
Notes for this study:
||n/dl. mean and SD. Placebo: before 45.3 ± 5.3, after 45.8±12.7 . Intervention: before 46.3 ± 4.3, after 45.6 ± 8.7.
|Number of Subjects
In a randomized, double-blind, placebo-controlled trial, 60 diabetic participants with coronary heart disease were allocated to 100 mg/day of coq10 or placebo for 8 weeks.
LP(a), AGEs, and thiols weren't different compared with placebo, but IL-6 saw a statistically significant decrease and so did protein carbonyls.